Anti-ror1 antibodies
作者： Christian Rohlff , Jonathan Alexander Terrett , Alasdair Stamps
DOI:
关键词:
摘要: The invention provides antibodies which bind to the extracellular domain of Tyrosine-protein kinase transmembrane receptor ROR1. Nucleic acid molecules encoding antibodies, expression vectors, host cells and methods for expressing are also provided. may be used treatment cancer, including non-small cell lung carcinoma, B-cell chronic lymphocytic leukemia colon cancer.
glgoo.top参考文章(125)
Marvin Burns, Pre-filled ampule and non-invasive hypodermic injection device assembly ,(1988)
Markus Warmuth, Karin Foster, Ror1 as a therapeutic target for lung cancer ,(2007)
Clair G. La Zor, Instrument for locating faults in aircraft passenger reading light and attendant call control system ,(1981)
G. M. Grass, J. R. Robinson, Sustained- and controlled-release drug delivery systems Drugs and the pharmaceutical sciences. ,vol. 40, pp. 635- 671 ,(1978)
Carl-Wilhelm Vogel, Immunoconjugates : antibody conjugates in radioimaging and therapy of cancer Oxford University Press. ,(1987)
Sivasubramanian Baskar, Christoph Rader, Anti-human ror1 antibodies ,(2010)
James Ferrara, Therapeutic device for administering medicaments through the skin ,(1983)
Patrick Henry Beusker, Franciscus Marinus Hendrikus De Groot, Triazole-Containing Releasable Linkers, Conjugates Thereof, and Methods of Preparation ,(2006)
Emmanuel Pitsinos, Adrian L. Smith, Kyriacos C. Nicolaou, Chan-Kou Hwang, Analogs of calicheamicin gamma1I, method of making and using the same ,(1992)